Lori J Braender is SVP, General Counsel of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 313,231 shares of AQST, which is worth approximately $1.13 Million. The most recent transaction as insider was on Mar 09, 2024, when has been sold 10,530 shares (Common Stock) at a price of $4.88 per share, resulting in proceeds of $51,386. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 313K
0% 3M change
65.94% 12M change
Total Value Held $1.13 Million

LORI J BRAENDER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 09 2024
SELL
Payment of exercise price or tax liability
$51,386 $4.88 p/Share
10,530 Reduced 3.25%
313,231 Common Stock
Mar 07 2024
BUY
Grant, award, or other acquisition
-
135,000 Added 29.43%
323,761 Common Stock
Mar 09 2023
BUY
Grant, award, or other acquisition
-
150,000 Added 44.28%
188,761 Common Stock
Jun 08 2022
BUY
Open market or private purchase
$13,211 $0.96 p/Share
13,761 Added 26.2%
38,761 Common Stock
LJB

Lori J Braender

SVP, General Counsel
Warren, NJ

Track Institutional and Insider Activities on AQST

Follow Aquestive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

News

Receive news related to Aquestive Therapeutics, Inc.

Track Activities on AQST